We assessed rimantadine antiviral effects in vivo using a preclinical ZIKV infection model (Pingen et al., 2016) comprising C57BL/6 mice and transient blockade of the interferon alpha receptor type 1 (IFNAR1). Here, IFNAR1 is linked to Zika virus infectious disease.